1,876
Views
0
CrossRef citations to date
0
Altmetric
Research Paper

M6A modification regulates tumor suppressor DIRAS1 expression in cervical cancer cells

, , , , , & ORCID Icon show all
Article: 2306674 | Received 22 Oct 2023, Accepted 14 Jan 2024, Published online: 19 Feb 2024

References

  • Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–9. doi:10.3322/caac.21660.
  • Canfell K, Kim JJ, Brisson M, Keane A, Simms KT, Caruana M, Burger EA, Martin D, Nguyen DTN, Bénard É, et al. Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet. 2020;395(10224):591–603. doi:10.1016/s0140-6736(20)30157-4.
  • Brisson M, Kim JJ, Canfell K, Drolet M, Gingras G, Burger EA, Martin D, Simms KT, Bénard É, Boily M-C, et al. Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet. 2020;395(10224):575–90. doi:10.1016/s0140-6736(20)30068-4.
  • Mutlu L, Tymon-Rosario J, Harold J, Menderes G. Targeted treatment options for the management of metastatic/persistent and recurrent cervical cancer. Expert Rev Anticancer Ther. 2022;22(6):633–45. doi:10.1080/14737140.2022.2075348.
  • Kontani K, Tada M, Ogawa T, Okai T, Saito K, Araki Y, Katada T. Di-ras, a distinct subgroup of ras family GTPases with unique biochemical properties. J Biol Chem. 2002;277(43):41070–41078. doi:10.1074/jbc.M202150200.
  • Xu X, Li J, Wang S, Zheng X, Xie L. Rnaa and Vector-mediated overexpression of DIRAS1 suppresses tumor growth and migration in renal cell carcinoma. Mol Ther Nucleic Acids. 2018;12:845–53. doi:10.1016/j.omtn.2018.07.019.
  • Sutton MN, Yang H, Huang GY, Fu C, Pontikos M, Wang Y, Mao W, Pang L, Yang M, Liu J, et al. RAS-related GTPases DIRAS1 and DIRAS2 induce autophagic cancer cell death and are required for autophagy in murine ovarian cancer cells. Autophagy. 2018;14(4):637–53. doi:10.1080/15548627.2018.1427022.
  • Zheng R, Gao D, He T, Zhang M, Zhang X, Linghu E, Wei L, Guo M. Methylation of DIRAS1 promotes colorectal cancer progression and may serve as a marker for poor prognosis. Clin Epigenetics. 2017;9(1):50. doi:10.1186/s13148-017-0348-0.
  • Rothhammer-Hampl T, Liesenberg F, Hansen N, Hoja S, Delic S, Reifenberger G, Riemenschneider MJ. Frequent epigenetic inactivation of DIRAS-1 and DIRAS-2 contributes to chemo-resistance in gliomas. Cancers Basel. 2021;13(20):5113. doi:10.3390/cancers13205113.
  • Zhu YH, Fu L, Chen L, Qin YR, Liu H, Xie F, Zeng T, Dong S-S, Li J, Li Y, et al. Downregulation of the novel tumor suppressor DIRAS1 predicts poor prognosis in esophageal squamous cell carcinoma. Cancer Res. 2013;73(7):2298–309. doi:10.1158/0008-5472.Can-12-2663.
  • Deans C, Maggert KA. What do you mean, “epigenetic”? Genetics. 2015;199(4):887–96. doi:10.1534/genetics.114.173492.
  • Smith ZD, Meissner A. DNA methylation: roles in mammalian development. Nat Rev Genet. 2013;14(3):204–20. doi:10.1038/nrg3354.
  • Xiao C, Fan T, Tian H, Zheng Y, Zhou Z, Li S, Li C, He J. H3K36 trimethylation-mediated biological functions in cancer. Clin Epigenetics. 2021;13(1):199. doi:10.1186/s13148-021-01187-2.
  • Pan Y, Ma P, Liu Y, Li W, Shu Y. Multiple functions of m(6)A RNA methylation in cancer. J Hematol Oncol. 2018;11(1):48. doi:10.1186/s13045-018-0590-8.
  • Brandt AC, Koehn OJ, Williams CL. SmgGDS: an emerging master regulator of prenylation and trafficking by small GTPases in the ras and rho families. Front Mol Biosci. 2021;8:685135. doi:10.3389/fmolb.2021.685135.
  • Gonyo P, Bergom C, Brandt AC, Tsaih SW, Sun Y, Bigley TM, Lorimer EL, Terhune SS, Rui H, Flister MJ, et al. SmgGDS is a transient nucleolar protein that protects cells from nucleolar stress and promotes the cell cycle by regulating DREAM complex gene expression. Oncogene. 2017;36(50):6873–83. doi:10.1038/onc.2017.280.
  • Bergom C, Hauser AD, Rymaszewski A, Gonyo P, Prokop JW, Jennings BC, Lawton AJ, Frei A, Lorimer EL, Aguilera-Barrantes I, et al. The tumor-suppressive small GTPase DiRas1 binds the noncanonical guanine nucleotide exchange factor SmgGDS and antagonizes SmgGDS interactions with oncogenic small GTPases. J Biol Chem. 2016;291(12):6534–45. doi:10.1074/jbc.M115.696831.
  • Barrón-Gallardo CA, Garcia-Chagollán M, Morán-Mendoza AJ, Delgadillo-Cristerna R, Martínez-Silva MG, Villaseñor-García MM, Aguilar-Lemarroy A, Jave-Suárez LF. A gene expression signature in HER2+ breast cancer patients related to neoadjuvant chemotherapy resistance, overall survival, and disease-free survival. Front Genet. 2022;13:991706. doi:10.3389/fgene.2022.991706.
  • Verma SP, Agarwal A, Das P. Sodium butyrate induces cell death by autophagy and reactivates a tumor suppressor gene DIRAS1 in renal cell carcinoma cell line UOK146. Vitro Cell Dev Biol Anim. 2018;54(4):295–303. doi:10.1007/s11626-018-0239-5.
  • Wang X, Li Z, Kong B, Song C, Cong J, Hou J, Wang S. Reduced m(6)A mRNA methylation is correlated with the progression of human cervical cancer. Oncotarget. 2017;8(58):98918–98930. doi:10.18632/oncotarget.22041.
  • Huo FC, Zhu ZM, Du WQ, Pan YJ, Jiang X, Kang MJ, Liu B-W, Mou J, Pei D-S. HPV E7-drived ALKBH5 promotes cervical cancer progression by modulating m6A modification of PAK5. Pharmacol Res. 2023;195:106863. doi:10.1016/j.phrs.2023.106863.
  • Huang J, Yang J, Zhang Y, Lu D, Dai Y. FTO promotes cervical cancer cell proliferation, colony formation, migration and invasion via the regulation of the BMP4/Hippo/YAP1/TAZ pathway. Exp Cell Res. 2023;427(1):113585. doi:10.1016/j.yexcr.2023.113585.
  • Zhou S, Bai ZL, Xia D, Zhao ZJ, Zhao R, Wang YY, Zhe H. FTO regulates the chemo-radiotherapy resistance of cervical squamous cell carcinoma (CSCC) by targeting β-catenin through mRNA demethylation. Mol Carcinog. 2018;57(5):590–597. doi:10.1002/mc.22782.
  • Xiao W, Adhikari S, Dahal U, Chen YS, Hao YJ, Sun BF, Sun H-Y, Li A, Ping X-L, Lai W-Y, et al. Nuclear m(6)A Reader YTHDC1 Regulates mRNA Splicing. Mol Cell. 2016;61(4):507–519. doi:10.1016/j.molcel.2016.01.012.
  • Roundtree IA, Luo GZ, Zhang Z, Wang X, Zhou T, Cui Y, Sha J, Huang X, Guerrero L, Xie P, et al., YTHDC1 mediates nuclear export of N(6)-methyladenosine methylated mRnas. Elife. 2017;6:e31311. doi:10.7554/eLife.31311.
  • Hsu PJ, Zhu Y, Ma H, Guo Y, Shi X, Liu Y, Qi M, Lu Z, Shi H, Wang J, et al. Ythdc2 is an N(6)-methyladenosine binding protein that regulates mammalian spermatogenesis. Cell Res. 2017;27(9):1115–1127. doi:10.1038/cr.2017.99.
  • Wang X, Zhao BS, Roundtree IA, Lu Z, Han D, Ma H, Weng X, Chen K, Shi H, He C, et al. N(6)-methyladenosine modulates messenger RNA translation efficiency. Cell. 2015;161(6):1388–1399. doi:10.1016/j.cell.2015.05.014.
  • Wang X, Lu Z, Gomez A, Hon GC, Yue Y, Han D, Fu Y, Parisien M, Dai Q, Jia G, et al. N6-methyladenosine-dependent regulation of messenger RNA stability. Nature. 2014;505(7481):117–20. doi:10.1038/nature12730.
  • Shi H, Wang X, Lu Z, Zhao BS, Ma H, Hsu PJ, Liu C, He C. YTHDF3 facilitates translation and decay of N(6)-methyladenosine-modified RNA. Cell Res. 2017;27(3):315–328. doi:10.1038/cr.2017.15.
  • Huang H, Weng H, Sun W, Qin X, Shi H, Wu H, Zhao BS, Mesquita A, Liu C, Yuan CL, et al. Recognition of RNA N(6)-methyladenosine by IGF2BP proteins enhances mRNA stability and translation. Nat Cell Biol. 2018;20(3):285–295. doi:10.1038/s41556-018-0045-z.